<HashMap><database>GEO</database><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328109</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia</name><description>Haploinsufficiency of the gene progranulin (GRN) is a major cause of frontotemporal dementia (FTD), for which there are no effective therapies. We developed a novel strain of mice expressing a human GRN transgene bearing a four base pair deletion in exon 5 (GRNc.388_391delCAGT) that causes FTD. Characterization of mice expressing the mutant transgene (GRNmEx5) indicates that GRNmEx5 is expressed at low levels and retains partial function. The GRNmEx5 protein partially rescues progranulin nullizygous-associated neuropathology and transcriptomic dysfunction. The Grn-/-; GRNmEx5 model provides insight into progranulin biology, increases our understanding of a pathogenic variant that causes FTD, and facilitates the development of GRN gene therapies.</description><dates><publication>2026/05/31</publication></dates><accession>GSE328109</accession><cross_references><GSM>GSM9672537</GSM><GSM>GSM9672538</GSM><GSM>GSM9672539</GSM><GSM>GSM9672540</GSM><GSM>GSM9672541</GSM><GSM>GSM9672542</GSM><GSM>GSM9672543</GSM><GSM>GSM9672532</GSM><GSM>GSM9672533</GSM><GSM>GSM9672534</GSM><GSM>GSM9672535</GSM><GSM>GSM9672536</GSM><GPL>19057</GPL><GSE>328109</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>